Estrella Immunopharma (ESLA) EPS (Basic) (2021 - 2026)
Estrella Immunopharma (ESLA) posted quarterly EPS (Basic) of -$0.05 for Q1 2026, up 94.27% year-over-year from -$0.03 in Q1 2025, and down 194.03% quarter-over-quarter from $0.06 in Q4 2025.
Estrella Immunopharma (ESLA) EPS (Basic) (2021 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported EPS (Basic) for 6 consecutive years, with -$0.05 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 94.27% year-over-year to -$0.05; the TTM figure through Mar 2026 stood at -$0.25 (up 97.05% YoY), while the FY2025 annual figure was -$0.28, up 92.98% from the prior year.
- EPS (Basic) declined to -$0.05 in Q1 2026 per ESLA's latest filing, from $0.06 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.06 in Q4 2025 and bottomed at -$33.91 in Q4 2022.
- Historically, EPS (Basic) has averaged -$2.82 across 5 years, with a median of -$0.22 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 29348.33% — and 2025, when it surged 102.9%.
- Estrella Immunopharma's EPS (Basic) stood at -$33.91 in 2022, then soared by 99.91% to -$0.03 in 2023, then plunged by 6793.37% to -$2.0 in 2024, then soared by 102.9% to $0.06 in 2025, then slumped by 194.03% to -$0.05 in 2026.
- Business Quant data shows ESLA's EPS (Basic) at -$0.05 in Q1 2026, $0.06 in Q4 2025, and -$2.17 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Estrella Immunopharma | 32.24 Mn | 32.10 Mn | - | -0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.05 |
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | -2.17 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.95 |
| Dec 31, 2024 | -2.00 |
| Sep 30, 2024 | -0.22 |
| Jun 30, 2024 | -0.12 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | -1.78 |
| Jun 30, 2023 | -0.10 |
| Mar 31, 2023 | -5.92 |
| Dec 31, 2022 | -33.91 |
| Sep 30, 2022 | -0.24 |
| Jun 30, 2022 | -0.25 |
| Mar 31, 2022 | -0.10 |
| Dec 31, 2021 | -0.12 |
| Sep 30, 2021 | -0.08 |